Pseudoexfoliation (PEX) syndrome (PES) is characterized by the widespread deposition of abnormal extracellular fibrillary material on many ocular and extraocular tissues. The objective of this study was to evaluate the association among PES, PEX glaucoma (PEG), and mean platelet volume (MPV).
Methods
Forty patients with PES (mean age 62.6 ± 7.8 years), 31 with PEG (mean age 65.9 ± 6.6 years), and 37 healthy individuals (control group) (mean age 64.0 ± 7.1 years) were included in the study. The MPV of the 3 groups were compared.
Results
Age and sex distribution were similar among groups (p>0.05). Mean MPV in PES, PEG, and control groups were 9.59 ± 0.94 fl, 9.53 ± 0.80 fl, and 7.7 ± 0.67 fl, respectively. In the PEX group, MPV values were significantly higher than in the control group (p<0.05). However, there was no difference between the PES and PEG groups (p>0.05).
Conclusions
The MPV values in both groups with PEX were higher than those in the healthy group.
Schlötzer-SchrehardtU.M., KocaM.R., NaumannG.O.H., VolkholzH.. Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder?Arch Ophthalmol1992; 110: 1752–6.
2.
StreetenB.W., LiZ.Y., WallaceR.N., EagleR.C.Jr., KeshgegianA.A.. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome.Arch Ophthalmol1992; 110: 1757–62.
StreetenB.W., LiZ.Y., WallaceR.N., EagleR.C.Jr., KeshgegianA.A.. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome.Arch Ophthalmol1992; 110: 1757–62.
6.
BertelsenT.I., DrablosP.A., FloodP.R.. The so-called senile exfoliation (pseudoexfoliation) of the anterior lens capsule, a product of the lens epithelium: fibrillopathia epitheliocapsularis: a microscopic, histochemic, and electron microscopic investigation.Acta Ophthalmol1964; 42: 1096–113.
7.
MitchellP., WangJ.J., SmithW.. Association of pseudoexfoliation syndrome with increased vascular risk.Am J Ophthalmol1997; 124: 685–7.
8.
KozC., TurkcuF., GurbuzO.. Endothelial function and novel vascular risk factors in pseudoexfoliation syndrome.Turkiye Klinikleri J Medi Sci2009; 29: 1510–6.
9.
ParkY., SchoeneN., HarrisW.. Mean platelet volume as an indicator of platelet activation: methodological issues.Platelets2002; 13: 301–6.
10.
VagdatliE., GounariE., LazaridouE., KatsibourliaE., TsikopoulouF., LabrianouI.. Platelet distribution width: a simple, practical and specific marker of activation of coagulation.Hippokratia2010; 14: 28–32.
11.
BathP., AlgertC., ChapmanN., NealB.; PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease.Stroke2004; 35: 622–6.
12.
EndlerG., KlimeschA., Sunder-PlassmannH.. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease.Br J Haematol2002; 117: 399–404.
13.
RitchR., Schlötzer-SchrehardtU., KonstasA.G.. Why is glaucoma associated with exfoliation syndrome?Prog Retin Eye Res2003; 22: 253–75.
CitirikM., AcarogluG., BatmanC., YildiranL., ZileliogluO.. A possible link between the pseudoexfoliation syndrome and coronary artery disease.Eye2007; 21: 11–5.
16.
RepoL.P., TeräsvirtaM.E., KoivistoK.J.. Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients.Ophthalmology1993; 100: 352–5.
17.
SchumacherS., Schlötzer–SchrehardtU., MartusP., LangW., NaumannG.O.. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta.Lancet2001; 357: 359–60.
18.
Schlötzer-SchrehardtU., KüchleM., NaumannG.O.. Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue.Arch Ophthalmol1991; 109: 565–70.
19.
AtalarP.T., AtalarE., KiliçH.. Impaired systemic endothelial function in patients with pseudoexfoliation syndrome.Int Heart J2006; 47: 77–84.
20.
CelermajerD.S., SorensenK.E., GoochV.M.. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.Lancet1992; 340: 1111–5.
21.
LandmasserU., HarrisonD.G., DrexlerH.. Oxidant stress a major cause of reduced endothelial nitric oxide availability in cardiovascular disease.Eur J Clin Pharmacol2006; 62: 13–19.
22.
JurcuţR., ArsenescuI., PuşcariuT.. Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina?Rom J Intern Med2005; 43: 199–209.
23.
GasparyanA.Y., AyvazyanL., MikhailidisD.P., KitasG.D.. Mean platelet volume: a link between thrombosis and inflammation?Curr Pharm Des2011; 17: 47–58.
24.
TavilY., SenN., YaziciH.U., HizalF., AbaciA., CengelA.. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease.Thromb Res2007; 120: 245–50.
25.
ZhongZ.L., HanM., ChenS.. Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus.Int J Ophthalmol2011; 4: 182–5.
26.
AcikgozN., KarincaogluY., ErmisN.. Increased mean platelet volume in Behçet's disease with thrombotic tendency.Tohoku J Exp Med2010; 221: 119–23.
27.
RicartJ.M., EspañaF., NavarroS., TodolíJ., Miguel De la FuenteJ., VayáA.. Mean platelet volume does not seem to relate to thrombosis or posterior uveitis in Behçet's disease.Clin Hemorheol Microcirc Epub2012.
